Canadian Journal of Kidney Health and Disease (Nov 2015)

CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitides – Executive Summary

  • Lucy McGeoch,
  • Marinka Twilt,
  • Leilani Famorca,
  • Volodko Bakowsky,
  • Lillian Barra,
  • Susan Benseler,
  • David A. Cabral,
  • Simon Carette,
  • Gerald P. Cox,
  • Navjot Dhindsa,
  • Christine Dipchand,
  • Aurore Fifi-Mah,
  • Michele Goulet,
  • Nader Khalidi,
  • Majed M. Khraishi,
  • Patrick Liang,
  • Nataliya Milman,
  • Christian A. Pineau,
  • Heather Reich,
  • Nooshin Samadi,
  • Kam Shojania,
  • Regina Taylor-Gjevre,
  • Tanveer E. Towheed,
  • Judith Trudeau,
  • Michael Walsh,
  • Elaine Yacyshyn,
  • Christian Pagnoux

DOI
https://doi.org/10.1186/s40697-015-0078-1
Journal volume & issue
Vol. 2

Abstract

Read online

The Canadian Vasculitis research network (CanVasc) is composed of physicians from different medical specialties, including rheumatology and nephrology and researchers with expertise in vasculitis. One of its aims was to develop recommendations for the diagnosis and management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides in Canada. This executive summary features the 19 recommendations and 17 statements addressing general AAV diagnosis and management, developed by CanVasc group based on a synthesis of existing international guidelines, other published supporting evidence and expert consensus considering the Canadian healthcare context.